Polydex Pharmaceuticals Limited reported unaudited consolidated financial results for the third quarter and nine months ended Oct. 31, 2018. For the quarter, sales were $1,158,846 against $1,434,587 for the same period of last year. Net income was $34,632 against $233,731 for the same period of last year. Income per basic share was $0.01 against $0.07 for the same period of last year. For the nine months, sales were $3,906,632 against $3,969,294 for the same period of last year. Net income was $199,729 against $362,795 for the same period of last year. Income per basic share was $0.06 against $0.11 for the same period of last year.